Skip to main content
TipRanks
Go Ultimate75% OFF

Tanvex Biopharma (6541) Balance Sheet

Tanvex Biopharma Balance Sheet

Tanvex Biopharma's total assets for Q2 2026 were NT$7.63B, a decrease of 0.04% from the previous quarter. TW:6541 total liabilities were NT$2.67B for the fiscal quarter, a 17.39% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 7.96BNT$ 2.74BNT$ 2.76BNT$ 3.42BNT$ 4.71B
NT$ 2.27BNT$ 1.84BNT$ 1.94BNT$ 2.03BNT$ 1.92B
NT$ 5.69BNT$ 893.31MNT$ 821.11MNT$ 1.39BNT$ 2.79B

Currency in TWD

Tanvex Biopharma Liabilities to Assets

03B6B9B0 %25 %50 %75 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets